Beyond these in vitro phenomena, ISO induced autophagy in vivo, in mouse tissues, and enhanced the immune response induced by immunogenic chemotherapy against established tumors, thus improving tumor growth control through mechanisms that rely on T cells as well as AKT inhibition and autophagy induction in the cancer cells. The gene discussed is AKT1; the disease is neoplasm.